Author

Serena Maiocchi

University of TriesteORCID 0000-0002-5886-5731Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Davide SelvestreliD· 1 shared Licio CollaviniD· 1 shared Luca BragaiD· 1 shared Luca L. FavaiD· 1 shared Maria Chiara MatteviiD· 1 shared Monica Rossin· 1 shared Raffaella KlimaiD· 1 shared Rossella De Florian FaniaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Davide SelvestrelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBiomoleculesPeer-reviewedAug 8, 2025

Drug-repurposing screen identifies thiostrepton as a novel regulator of the tumor suppressor DAB2IP

Rossella De Florian Fania, Serena Maiocchi, Raffaella Klima…·Licio Collavin

The paper screens FDA-approved drugs to find those that increase DAB2IP protein levels, identifying thiostrepton as a potential anti-cancer agent that relies on DAB2IP for its tumor-suppressive effect.

DOI 10.3390/biom15081147

humanproteomics

𝕏 PostBluesky